Slide 1: 2008 Preliminary results
Milan, Conference Call, 11 February 2009 2008 Preliminary results Outlook for 2009
Slide 2: 2008 Highlights
2008 Highlights • Revenue R € 689.6 689 6 million, illi up 9 9.7%, 7% iinternational t ti l sales l grow b by 13 13.9% 9% • EBIT € 144.7 million, up 10.1% • Net income € 100.4 million, up 18.3% • Acquisition q of FIC and FIC Médical, our distribution arm in Russia and other C.I.S. countries • New le
Slide 3: Composition of revenue
Composition of revenue (million Euro) 2008 2007 Change % Italyy 195.5 201.3 ( ) (2.8) France 144.5 140.5 2.9 Germany 53.8 52.8 1.9 Portugal 42 9 42.9 45 7 45.7 (6 1) (6.1) Spain 25.9 21.9 18.0 United Kingdom 10.6 11.6 (8.9) Other European countries 5.3 2.5 n.s. C.I.S. countries 22.5 13.2 69.7 Other
Slide 4: Breakdown of pharmaceutical revenue
Breakdown of pharmaceutical revenue Other European countries 1% i UK Spain S C.I.S. C IS Portugal 4% 2% 3% Other international sales 6% 17% Germany 8% Orphan Europe 7% France 22% Total revenue Italy Pharmaceuticals 30% 95% Data: Full year 2008 Total revenue € 690 m 5% Pharmaceutical revenue € 658 m
Slide 5: Full year 2008 results
Full year 2008 results (million Euro) 2008 2007 Change % Revenue 689.6 628.4 9.7 Gross Profit 467.4 422.1 10.7 as % of revenue 67.8% 67.2% SG&A Expenses 253.6 236.0 7.5 as % of revenue 36.8% 37.6% R&D Expenses 58 9 58.9 49 1 49.1 19 8 19.8 as % of revenue 8.5% 7.8% Other Income (Expense), net (10.2)
Slide 6: Fourth quarter 2008 results
Fourth quarter 2008 results (million Euro) 4Q 2008 4Q 2007 Change % Revenue 181 4 181.4 162 0 162.0 12 0 12.0 Gross Profit 120.8 106.1 13.8 as % of revenue 66.6% 65.5% SG&A Expenses 63.3 60.3 4.8 as % of revenue 34.9% 37.2% R&D E Expenses 16 6 16.6 12 3 12.3 35 4 35.4 as % of revenue 9.1% 7.6% Other
Slide 7: Growth targets
Growth targets 2009 Change growth % 2008 (million Euro) t targets t Revenue ~ 750 +9% 689.6 R&D expenses ~ 75 +27% 58.9 Operating income ~ 155 +7% 144.7 (EBIT) Net Income ~ 105 +5% 100.4 6
Slide 8: Company declarations, disclaimers and profile
Company declarations, disclaimers and profile DECLARATION BY THE MANAGER RESPONSIBLE FOR PREPARING THE COMPANY’S FINANCIAL REPORTS The manager responsible for preparing the company’s financial reports Fritz Squindo declares, pursuant to paragraph 2 of Article 154-bis of the Consolidated Law on Finan